| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |